Kidney cancer therapy: new perspectives and avenues-Reference-Cited by-同舟云学术

Kidney cancer therapy: new perspectives and avenues

Published:2006-12 Issue:18 Volume:7 Page:2481-2493
ISSN:1465-6566
Container-title:Expert Opinion on Pharmacotherapy
language:en
Short-container-title:Expert Opinion on Pharmacotherapy

Author:

Alexandrescu Doru T,Dasanu Constantin A

Publisher

Informa Healthcare

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.1517/14656566.7.18.2481

Reference86 articles.

1. LINEHAN WM, ZBAR B, BATES SEetal.: Cancer of the kidney and ureter. In:Cancer:Principles andPracticeofOncology,6thedn. DeVita VT Jr, Hellman S, Rosenberg SA (Eds), Lippincott, Williams & Wilkins, Philadelphia, PA (2001):1362-1396.

2. Treatment of Metastatic Renal Cell Carcinoma with Recombinant Interleukin-2 in Combination with Vinblastine or Lymphokine-Activated Killer Cells

3. Treatment of metastatic renal cell carcinoma by continuous intravenous infusion of recombinant interleukin-2: a single-center phase II study.

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

Optimal Management of First-Line Advanced Renal Cell Carcinoma: Focus on Pembrolizumab

;OncoTargets and Therapy;2020-05

2. Immunomodulatory Therapies for Renal Cell Carcinoma;Protein & Peptide Letters;2018-08-28

3. G3BP1 promotes tumor progression and metastasis through IL-6/G3BP1/STAT3 signaling axis in renal cell carcinomas;Cell Death & Disease;2018-05

4. Interleukin-6 as an emerging regulator of renal cell cancer;Urologic Oncology: Seminars and Original Investigations;2015-11

5. Temsirolimus;Recent Results in Cancer Research;2014